Overview and recent advances in the targeting of medulloblastoma cancer stem cells

Keyphrases

• 5-year Survival 50%
• Area Cover 25%
• Cancer Stem Cell Markers 25%
• Cancer Stem Cells 100%
• Central Nervous System 25%
• Clinical High Risk 25%
• Combined Modality Therapy 25%
• Developmental Biology 25%
• Epidemiology 25%
• Expert Opinion 25%
• Good Prognosis 25%
• Improved Outcomes 50%
• Malignancy 25%
• Medulloblastoma 100%
• Medulloblastoma Cancer 100%
• Molecular Subgroups 50%
• Molecular Subtypes 25%
• Overall Survival Rate 50%
• Poor Prognosis 25%
• Posterior Fossa 25%
• Primary Disease 25%
• Recent Advances 100%
• Refractory Disease 25%
• Relapsed Disease 50%
• Resistant Cells 25%
• Risk Stratification 50%
• Small Round Blue Cell Tumors 25%
• Stem Cell Biology 25%
• Subgroup Analysis 25%
• Targeted Treatment 25%
• Targeting Cancer Stem Cells 25%
• Treatment Modalities 25%
• Treatment Refractory 25%
• Treatment-resistant 25%
• Tumor 25%
• Understanding of Cancer 25%

Medicine and Dentistry

• Cancer 20%
• Cancer Pathobiology 20%
• Cancer Stem Cell 100%
• Cell Marker 20%
• Central Nervous System 20%
• Cohort Effect 20%
• Cytotechnology 20%
• Diseases 60%
• Medulloblastoma 100%
• Neoplasm 20%
• Overall Survival 40%
• Posterior Fossa 20%
• Risk Stratification 40%
• Small-Blue-Round-Cell Tumor 20%
• Subgroup Analysis 20%
• Survival Rate 40%
• Targeted Therapy 20%
• Treatment Modality 20%